Clinical Trials Directory

Trials / Completed

CompletedNCT04448418

The Impact of COVID-19 Outbreak on Trans-population's Health in Italy

Observational Evaluation of the Impact of COVID-19 Outbreak on Transgender Subject's Health and on the Organization of Trans-population Health Care Services

Status
Completed
Phase
Study type
Observational
Enrollment
111 (actual)
Sponsor
Unita Complessa di Ostetricia e Ginecologia · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

During the COVID-19 outbreak, it was necessary to remodel the healthcare offer for all categories of subjects in order to minimize unnecessary movements of people while maintaining an adequate level of assistance. This is also true for transgender people, who are periodically requested to come into the clinic for hormonal therapy monitoring and continuation. In our center telemedicine programs dedicated to users have been activated for the remote management of hormone therapy. We use a web-based survey to assess the impact of COVID-19 outbreak on trans-population health and to assess the specific needs of this population in this particular moment.

Detailed description

Use of a dedicated web-based anonymous questionnaire to assess health needs of trans-population during COVID-19 outbreak and to assess specific risk factors for COVID-19 infection. Evaluation of physical and psychological wellbeing of the trans-population during COIVD-19 outbreak in Italy using anonymous validated questionnaires (SF12, IES-R and BECK DEPRESSION INVENTORY)

Conditions

Interventions

TypeNameDescription
OTHERweb based surveyAssess specific health care needs for the transpopulation during the COVID-19 outbreack using a newly created questionnaire and some validated questionnaries (Impact of Event Scale-Revised, BECK Depression Inventory and the Self-rated Health SF-12)

Timeline

Start date
2020-05-20
Primary completion
2020-06-20
Completion
2020-06-20
First posted
2020-06-25
Last updated
2021-04-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04448418. Inclusion in this directory is not an endorsement.